Nasus Pharma CEO Issues 2025 Letter to Shareholders
Nasus Pharma CEO Issues 2025 Letter to Shareholders GlobeNewswire December 22, 2025 TEL AVIV, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) — Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma”, “Nasus” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions, today issued a letter to its […]